Agencies Hearing Report
Total Page:16
File Type:pdf, Size:1020Kb
STATE AGENCIES AND INTERIM HEARINGS By Hearing Date 10-25-2019 - 07:50:21 Anatomical Board of the State of Texas October 25, 2019 - 10:00 AM UT Health McGovern Medical School 6431 Fannin St, Houston Anatomical Board of the State of Texas Board Meeting UT Health McGovern Medical School 6431 Fannin St. Houston, Texas 77539 October 25, 2019 10:00 a.m. The Anatomical Board of the State of Texas will convene in a specially called meeting in Room MSB B.232 on the campus of the UT Health McGovern Medical School on October 25, 2019 at 10:00 a.m. to discuss and possibly act on the following agenda items: 1. Roll call, certification of a quorum, introduction of guests. 2. Introduction of newly appointed board members 3. Report on the Sunset Review Self-Evaluation Report 4. Approval of TAC changes approved at 6/29/2018 meeting 5. Review of and vote on proposed legislative changes to TAC Title 25 Part 4 or Health & Safety Code Chapter 691 presented at the May 31, 2019 meeting by Dr. Cleary. 6. UTMB interim audit 7. Public Comment. Additional Information Contact: Stephen Luk Department of State Health Services October 25, 2019 - 10:00 AM Department of State Health Services (DSHS), 1100 West 49th St, Moreton Building, Room M-100, Austin PROMOTOR(A) OR COMMUNITY HEALTH WORKER (CHW) TRAINING AND CERTIFICATION ADVISORY COMMITTEE Please check in with Security - someone will escort you to the Conference Room. Members of the public may attend the meeting in person at the address above or access a live stream of the meeting at: https://hhs.texas.gov/about-hhs/communications-events/live-archi ed-meetings. Select the tab for Moreton M-100 Live. 1. Welcome and introductions - Merida Escobar, Presiding Officer 2. Approval of minutes (July 26, 2019)* - Stephanie Gutierrez, HHSC, Advisory Committee Coordination Office 3. Health Promotion and Chronic Disease Prevention Section Update - Brett Spencer, Manager, Community Health and Wellness Branch 4.MAXIMUS-Promotores de Salud/CHW Field Operations - Merida Escobar, Region 11 Regional Supervisor, Maximus 5. Election of Advisory Committee Officers* - Merida Escobar, Presiding Officer 6. DSHS approved applications for certification and training institution: -Mental Health America of Greater Houston - provide continuing education for CHWs - Merida Escobar, Presiding Officer 7. Advisory Committee Sub-Committee Updates - Sub-Committee Leads 8. Program Update: Monica Maldonado, DSHS Promotor(a)/CHW Training and Certification Program Beatrice Smith, DSHS Promotor(a)/CHW Training and Certification Program 9. Committee Member Sharing - Merida Escobar, Presiding Officer 10. Public Comment - Stephanie Gutierrez, HHSC, Advisory Committee Coordination Office 11. Agenda items for next meeting 12. Adjourn - Merida Escobar, Presiding Officer *Action Item This meeting is open to the public. No reservations are required, and there is no cost to attend this meeting. Any person with a disability planning to attend this meeting and requiring any auxiliary aid or service is asked to contact Beatrice Smith, Promotor(a)/CHW Training and Certification Program, Department of State Health Services, at 512-776-2208 or [email protected], at least 72 hours prior to the meeting to make appropriate arrangements. Additional Information Contact: Beatrice Smith, 512/776-2208 October 25, 2019 - 10:00 AM Department of State Health Services (DSHS), 1100 West 49th St, Moreton Building, Room M-100, Austin PROMOTOR(A) OR COMMUNITY HEALTH WORKER (CHW) TRAINING AND CERTIFICATION ADVISORY COMMITTEE THIS AGENDA IS BEING REVISED TO CHANGE THE PRESENTER FOR ITEM NUMBER 4 FROM MERIDA ESCOBAR TO PEGGY GULLEDGE. Please check in with Security - someone will escort you to the Conference Room. Members of the public may attend the meeting in person at the address above or access a live stream of the meeting at: https://hhs.texas.gov/about-hhs/communications-events/live- archi ed-meetings. Select the tab for Moreton M-100 Live. 1. Welcome and introductions - Merida Escobar, Presiding Officer 2. Approval of minutes (July 26, 2019)* - Stephanie Gutierrez, HHSC, Advisory Committee Coordination Office 3. Health Promotion and Chronic Disease Prevention Section Update - Brett Spencer, Manager, Community Health and Wellness Branch 4.MAXIMUS-Promotores de Salud/CHW Field Operations - Peggy Gulledge, LMSW, CHW, Senior Manager, Texas Enrollment Broker Maximus 5. Election of Advisory Committee Officers* - Merida Escobar, Presiding Officer 6. DSHS approved applications for certification and training institution: -Mental Health America of Greater Houston - provide continuing education for CHWs - Merida Escobar, Presiding Officer 7. Advisory Committee Sub-Committee Updates - Sub-Committee Leads 8. Program Update: Monica Maldonado, DSHS Promotor(a)/CHW Training and Certification Program Beatrice Smith, DSHS Promotor(a)/CHW Training and Certification Program 9. Committee Member Sharing - Merida Escobar, Presiding Officer 10. Public Comment - Stephanie Gutierrez, HHSC, Advisory Committee Coordination Office 11. Agenda items for next meeting 12. Adjourn - Merida Escobar, Presiding Officer *Action Item This meeting is open to the public. No reservations are required, and there is no cost to attend this meeting. Any person with a disability planning to attend this meeting and requiring any auxiliary aid or service is asked to contact Beatrice Smith, Promotor(a)/CHW Training and Certification Program, Department of State Health Services, at 512-776-2208 or [email protected], at least 72 hours prior to the meeting to make appropriate arrangements. Additional Information Contact:Beatrice Smith, 512/776-220 October 25, 2019 - 08:00 AM University of Texas Southwestern, 6001 Forest Park Road, T. Boone Pickens Biomedical Building, NG3.112, Dallas Texas Council on Alzheimer's Disease and Related Disorders Members of the Texas Council on Alzheimer's Disease and Related Disorders may attend the following event to receive information concerning Alzheimer's disease and related disorders: Texas Alzheimer's Research and Care Consortium and the Peter O'Donnell Jr. Brain Institute International Symposium on Neurodegenerative Diseases and Reception at the University of Texas Southwestern, 6001 Forest Park Road, T. Boone Pickens Biomedical Building, NG3.112, Dallas, TX, 75390. No formal action or deliberations between or among members of the Texas Council on Alzheimer's Disease and Related Disorders will take place. Additional Information Contact: Lynda Taylor, 512/776-6618 Texas Health and Human Services Commission October 25, 2019 - 09:00 AM 4900 North Lamar Blvd. (Health and Human Services Commission, Brown Heatly Building, Public Hearing, Room, Room 1400), Austin Drug Utilization Review Board AGENDA: Drug Utilization Review Board October 25, 2019 9:00 a.m. Meeting Site: Health and Human Services Commission Brown Heatly Building Public Hearing Room, Room 1400 4900 North Lamar Blvd. Austin, TX 78751 This meeting will be webcast. To access the webcast, go to https://hhs.texas.gov/about-hhs/communications-events/live-archi ed-meetings the day and time of the meeting. 1. Call to order 2. Approval of minutes from July 25, 2019 (vote required) 3. New business: Public comment on drug classes to be reviewed for the Medicaid Preferred Drug List (PDL): a. Androgenic agents, topical b. Antibiotics, gastrointestinal (GI) c. Antibiotics, topical d. Antibiotics, vaginal e. Anticonvulsants f. Antiemetics/antivertigo agents g. Antifungals, oral h. Antifungals, topical i. Antihistamines - first generation j. Antiparasitics, topical k. Antipsychotics l. Antivirals, topical m. Bone resorption suppression and related agents n. Colony stimulating factors o. Cytokine and Cell Adhesion Molecule (CAM) antagonists p. Epinephrine, self-injected q. GI motility, chronic r. Growth hormone s. Hepatitis C agents t. Hypoglycemics, incretin mimetics/enhancers u. Hypoglycemics, insulin and related agents v. Hypoglycemics, meglitinides w. Hypoglycemics, metformin x. Hypoglycemics, sodium-glucose cotransporter-2 inhibitors (SGLT2) y. Hypoglycemics, thiazolidinedione (TZD) z. Macrolides/Ketolides aa. Opiate dependence treatments bb. Penicillins cc. Tetracyclines 4. Public comment and therapeutic and clinical drug reviews on new drugs to be reviewed for the Medicaid PDL: a. Emgality Syringe 100 mg / Antimigraine Agents, Other b. Tadalafil / Benign Prostatic Hyperplasia (BPH) Treatments c. Katerzia / Calcium Channel Blockers d. Cutaquig / Immune Globulins e. Ezallor Sprinkle / Lipotropics, Statins f. Lidopure, Zilacaine Patch / Neuropathic Pain g. Beser Kit / Steriods, Topical Medium h. Adhansia XR, Evekeo ODT, Jornay PM, Sunosi / Stimulants and Related Agents 5. Therapeutic and Clinical Drug Reviews and Updates: Matt Lennertz, Pharm. D., Magellan Medicaid Administration 6. Executive work session Pursuant to Texas Government Code Section 531.071, and in accordance with Texas Administrative Code Title 1, Part 15, Subchapter F, Section 354.1941(c)(2), the Drug Utilization Review (DUR) Board may meet in executive session on one or more items listed under new business as permitted by the Texas Open Meetings Act. 7. Announcements of drugs recommended for the Medicaid PDL: Matt Lennertz, Pharm. D., Magellan Medicaid Administration (vote required) 8. Retrospective drug use, criteria for outpatient use in Vendor Drug Program: Jennifer Seltzer, Pharm. D., University of Texas at Austin College of Pharmacy (vote required) a. Atypical antipsychotics - long-acting injectables b. Atypical antipsychotics - oral c.